FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606621222> ?p ?o ?g. }

• W2606621222 endingPage "599" @default.
• W2606621222 startingPage "593" @default.
• W2606621222 abstract "Molecular classification of bladder cancer has been increasingly proposed as a potential tool to predict clinical outcomes and responses to chemotherapy. Here we focused on mechanistic target of rapamycin (mTOR) inhibition as a chemotherapeutic strategy and characterized the expression profile of mTOR signaling targets in representative bladder cancer cell lines from basal, luminal, and either basal/luminal (non-type) molecular subtypes.Protein and mRNA expression of mTOR signaling components from representative luminal (RT4 and RT112), basal (SCaBER and 5637), and nontype (T24 and J82) bladder cancer cell line subtypes were determined by Western blot and database mining analysis of the Cancer Cell Line Encyclopedia. Cell viability following treatment with either, Torin-2 or KU-0063794, 2 dual mTOR complex 1/2 inhibitors, was determined by MTT assay. Immunoblot analysis of cells treated with Torin-2 or KU-0063794 was performed to determine the effects of mTOR inhibition on expression and phosphorylation status of mTOR signaling components, Akt, 4E-BP1, and ribosomal protein S6.Molecular subtypes of bladder cancer cell lines each exhibited a distinct pattern of expression of mTOR-associated genes and baseline phosphorylation level of Akt and 4E-BP1. Cells with low levels of Akt Ser-473 phosphorylation were more resistant to the cytotoxic effects of mTOR inhibition with Torin-2, but not KU-0063794. Exposure to Torin-2 and KU-0063794 both potently and rapidly inhibited phosphorylation of Akt Ser-473 and Thr-308, and 4E-BP1 T37/46 in cell lines that included basal and nontype subtypes.Differential gene expression and protein activity associated with mTOR signaling is observed among bladder cancer cell lines stratified into basal, luminal, and nontype subtypes. Urothelial carcinomas characterized by high baseline Akt Ser-473 phosphorylation may be best suited for targeted mTOR therapies." @default.
• W2606621222 created "2017-04-28" @default.
• W2606621222 creator A5002024579 @default.
• W2606621222 creator A5033375049 @default.
• W2606621222 creator A5038043437 @default.
• W2606621222 creator A5056780335 @default.
• W2606621222 creator A5063194488 @default.
• W2606621222 date "2017-10-01" @default.
• W2606621222 modified "2023-10-02" @default.
• W2606621222 title "Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition" @default.
• W2606621222 cites W1617495083 @default.
• W2606621222 cites W1725351598 @default.
• W2606621222 cites W1940068179 @default.
• W2606621222 cites W1965626427 @default.
• W2606621222 cites W1980808101 @default.
• W2606621222 cites W1985177501 @default.
• W2606621222 cites W1988303870 @default.
• W2606621222 cites W2017567246 @default.
• W2606621222 cites W2033775272 @default.
• W2606621222 cites W2043398720 @default.
• W2606621222 cites W2055983280 @default.
• W2606621222 cites W2058388635 @default.
• W2606621222 cites W2060142091 @default.
• W2606621222 cites W2067964015 @default.
• W2606621222 cites W2068523052 @default.
• W2606621222 cites W2093088536 @default.
• W2606621222 cites W2114492564 @default.
• W2606621222 cites W2114918609 @default.
• W2606621222 cites W2120745134 @default.
• W2606621222 cites W2121141015 @default.
• W2606621222 cites W2124614719 @default.
• W2606621222 cites W2127011486 @default.
• W2606621222 cites W2127046868 @default.
• W2606621222 cites W2127063807 @default.
• W2606621222 cites W2143112776 @default.
• W2606621222 cites W2149441684 @default.
• W2606621222 cites W2163941629 @default.
• W2606621222 cites W2252644942 @default.
• W2606621222 cites W2560018230 @default.
• W2606621222 doi "https://doi.org/10.1016/j.urolonc.2017.03.025" @default.
• W2606621222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28427860" @default.
• W2606621222 hasPublicationYear "2017" @default.
• W2606621222 type Work @default.
• W2606621222 sameAs 2606621222 @default.
• W2606621222 citedByCount "14" @default.
• W2606621222 countsByYear W26066212222017 @default.
• W2606621222 countsByYear W26066212222018 @default.
• W2606621222 countsByYear W26066212222019 @default.
• W2606621222 countsByYear W26066212222020 @default.
• W2606621222 countsByYear W26066212222021 @default.
• W2606621222 countsByYear W26066212222022 @default.
• W2606621222 crossrefType "journal-article" @default.
• W2606621222 hasAuthorship W2606621222A5002024579 @default.
• W2606621222 hasAuthorship W2606621222A5033375049 @default.
• W2606621222 hasAuthorship W2606621222A5038043437 @default.
• W2606621222 hasAuthorship W2606621222A5056780335 @default.
• W2606621222 hasAuthorship W2606621222A5063194488 @default.
• W2606621222 hasConcept C104202773 @default.
• W2606621222 hasConcept C11960822 @default.
• W2606621222 hasConcept C153911025 @default.
• W2606621222 hasConcept C2780926556 @default.
• W2606621222 hasConcept C43060935 @default.
• W2606621222 hasConcept C502942594 @default.
• W2606621222 hasConcept C53227056 @default.
• W2606621222 hasConcept C54355233 @default.
• W2606621222 hasConcept C55493867 @default.
• W2606621222 hasConcept C62112901 @default.
• W2606621222 hasConcept C62478195 @default.
• W2606621222 hasConcept C75217442 @default.
• W2606621222 hasConcept C81885089 @default.
• W2606621222 hasConcept C86554907 @default.
• W2606621222 hasConcept C86803240 @default.
• W2606621222 hasConcept C95444343 @default.
• W2606621222 hasConceptScore W2606621222C104202773 @default.
• W2606621222 hasConceptScore W2606621222C11960822 @default.
• W2606621222 hasConceptScore W2606621222C153911025 @default.
• W2606621222 hasConceptScore W2606621222C2780926556 @default.
• W2606621222 hasConceptScore W2606621222C43060935 @default.
• W2606621222 hasConceptScore W2606621222C502942594 @default.
• W2606621222 hasConceptScore W2606621222C53227056 @default.
• W2606621222 hasConceptScore W2606621222C54355233 @default.
• W2606621222 hasConceptScore W2606621222C55493867 @default.
• W2606621222 hasConceptScore W2606621222C62112901 @default.
• W2606621222 hasConceptScore W2606621222C62478195 @default.
• W2606621222 hasConceptScore W2606621222C75217442 @default.
• W2606621222 hasConceptScore W2606621222C81885089 @default.
• W2606621222 hasConceptScore W2606621222C86554907 @default.
• W2606621222 hasConceptScore W2606621222C86803240 @default.
• W2606621222 hasConceptScore W2606621222C95444343 @default.
• W2606621222 hasIssue "10" @default.
• W2606621222 hasLocation W26066212221 @default.
• W2606621222 hasLocation W26066212222 @default.
• W2606621222 hasOpenAccess W2606621222 @default.
• W2606621222 hasPrimaryLocation W26066212221 @default.
• W2606621222 hasRelatedWork W1972431686 @default.
• W2606621222 hasRelatedWork W2014649174 @default.
• W2606621222 hasRelatedWork W2045005486 @default.
• W2606621222 hasRelatedWork W2062497077 @default.

• next